^
Association details:
Biomarker:DDX11-AS1 overexpression
Cancer:Breast Cancer
Drug:paclitaxel (Tubulin inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
Title:

Knockdown of long non-coding RNA DDX11-AS1 inhibits the proliferation, migration and paclitaxel resistance of breast cancer cells by upregulating microRNA-497 expression

Published date:
02/16/2022
Excerpt:
The present study demonstrated that the expression levels of lncRNA DDX11‑AS1 were markedly increased in paclitaxel (PTX)‑resistant breast cancer cell lines.
DOI:
10.3892/mmr.2022.12639